000 01705 a2200517 4500
005 20250513233329.0
264 0 _c20010712
008 200107s 0 0 eng d
022 _a0300-5526
024 7 _a10.1159/000053996
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aIsaguliants, M G
245 0 0 _aDNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge.
_h[electronic resource]
260 _bIntervirology
_c2000
300 _a288-93 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAIDS Vaccines
_xadministration & dosage
650 0 4 _aAmino Acid Sequence
650 0 4 _aAnimals
650 0 4 _aCells, Cultured
650 0 4 _aDisease Models, Animal
650 0 4 _aHIV Infections
_xprevention & control
650 0 4 _aHIV Reverse Transcriptase
_xgenetics
650 0 4 _aHIV-1
_ximmunology
650 0 4 _aHumans
650 0 4 _aImmunization
650 0 4 _aLeukocytes, Mononuclear
650 0 4 _aMice
650 0 4 _aMice, Inbred C57BL
650 0 4 _aMolecular Sequence Data
650 0 4 _aMutation
650 0 4 _aPeptides
_xchemical synthesis
650 0 4 _aVaccines, DNA
_xadministration & dosage
700 1 _aPetrakova, N N
700 1 _aZuber, B
700 1 _aPokrovskaya, K
700 1 _aGizatullin, R
700 1 _aKostyuk, D A
700 1 _aKjerrström, A
700 1 _aWinberg, G
700 1 _aKochetkov, S N
700 1 _aHinkula, J
700 1 _aWahren, B
773 0 _tIntervirology
_gvol. 43
_gno. 4-6
_gp. 288-93
856 4 0 _uhttps://doi.org/10.1159/000053996
_zAvailable from publisher's website
999 _c11188151
_d11188151